Form 4 for IBRX ImmunityBio, Inc.
Accepted 2024-12-16 00:00:00 ET · period of report 2024-12-15 · accession 0001326110-24-000118 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-16 | 2024-12-15 | IBRX | LAUER REGAN J | CAO | M - OptEx | $0.00 | +21.0K | 115.4K | +22% | $0 |
| D | 2024-12-16 | 2024-12-15 | IBRX | LAUER REGAN J | CAO | F - Tax | $2.87 | -7,503 | 107.9K | -7% | -$21.5K |
| D | 2024-12-16 | 2024-12-15 | IBRX | LAUER REGAN J | CAO | M - OptEx | $0.00 | -21.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-15 | M | A | 21,031 | $0.00 | 115,365 | D | — | — | |
| 2 | Common | Common Stock | 2024-12-15 | F | D | 7,503 | $2.87 | 107,862 | D | — | — | (F1) On December 15, 2024, the Reporting Person's restricted stock units ("RSUs") vested. The closing price of Immunity Bio, Inc.'s common stock on December 13, 2024 was the settlement price used to calculate the shares withheld. |
| 3 | Derivative | Restricted Stock Units | 2024-12-15 | M | D | 21,031 | $0.00 | 0 | D | — · — to — | 21,031 Common Stock | (F2) Each RSU represents a contingent right to receive one share of ImmunityBio, Inc. common stock. (F3) Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the RSUs vested as follows: 1/3rd of the RSUs subject to the award vested June 15, 2023, 1/3rd of the RSUs subject to the award vested December 15, 2023, and 1/3rd of the RSUs subject to the award vested December 15, 2024 such that the award was fully vested on December 15, 2024. |